Pradaxa and Xarelto Similarities
Pradaxa and Xarelto
Almost 4,000 lawsuits related to a similar blood thinner, Pradaxa, recently settled for $650 million. Pradaxa plaintiffs sought damages for uncontrolled or fatal bleeding and claimed that Pradaxa manufacturer Boehringer Ingelheim failed to warn about those risks. Like Xarelto, Pradaxa also has no reversal agent to counteract its blood thinning effects.
Despite the mounting litigation and similarity to Pradaxa, Bayer and Johnson & Johnson are still seeking expanded FDA approvals, allowing them to market the blood thinner to a wider population of users. The FDA has rejected three previous attempts to expand Xarelto use, expressing concern about uncontrolled bleeding events linked to the drug.
Many plaintiffs are pushing for a Xarelto recall until a reversal agent is available.
Patients who have experienced uncontrolled bleeding or other similar side effects from using Xarelto may wish to speak to a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454 or by email at info(at)hkllp(dot)com.